NAD+ Injection Dosage

A standard NAD+ injection dosage is determined entirely by a prescribing clinician based on individual patient evaluation. Commonly, compounded NAD+ (Nicotinamide adenine dinucleotide) is formulated at a concentration of 200 mg/mL. Depending on the clinical protocol, the injected volume typically ranges from a small fraction of a milliliter up to a full milliliter per dose. When you consider this treatment. A licensed clinician reviews your intake and determines whether treatment is appropriate. You must understand that compounded medications are not FDA-approved but are prepared by state-licensed compounding pharmacies under Section 503A.

Understanding the dosage of NAD+ requires familiarity with how the molecule functions in the body and how concentration relates to the physical volume injected. This guide covers the mechanisms of NAD+, the rationale behind various dosage protocols, and the standard processes for intramuscular administration.

The Role of NAD+ in the Body

Nicotinamide adenine dinucleotide is a coenzyme found in all living cells. It is required for the fundamental biological processes that make life possible. NAD+ exists in two forms: an oxidized and reduced form. The molecule acts as an electron carrier in cellular respiration, facilitating the transfer of energy from the nutrients you consume into adenosine triphosphate, or ATP. ATP is the primary energy currency of the cell.

Beyond its role in energy metabolism, NAD+ is consumed by enzymes that regulate critical cellular functions. These enzymes include sirtuins, which are involved in cellular health and aging pathways, and PARPs, which are responsible for DNA repair. Because these enzymes physically consume NAD+ during their operation, the cellular supply of this coenzyme must be continuously replenished.

Clinical interest in NAD+ stems from observations regarding its systemic levels over time. Intramuscular injections of NAD+ are designed to bypass the digestive system and deliver the coenzyme directly into the tissue, where it can enter the systemic circulation and participate in these biochemical pathways.

Concentration and Volume Specifications

When discussing dosage, it is vital to distinguish between the concentration of the formulation and the volume administered. Concentration refers to the amount of the active ingredient dissolved in the liquid vehicle. Volume refers to the physical amount of liquid drawn into the syringe.

The standard concentration for the NAD+ product provided through this platform is 200 mg/mL. This means that every milliliter of the liquid contains 200 milligrams of Nicotinamide adenine dinucleotide.

If a clinician prescribes a dose of 100 milligrams, the corresponding volume to inject would be 0.5 mL. If the prescribed dose is 50 milligrams, the volume would be 0.25 mL. Patients must read their prescription labels carefully to ensure they are drawing the correct volume of fluid to match their prescribed milligram dosage. Using the incorrect volume can result in administering either a sub-therapeutic dose or a dose higher than the clinician intended.

Determining the Appropriate Protocol

There is no single universal dosage for NAD+ injections. The appropriate protocol is determined through a clinical evaluation. Clinicians consider a variety of factors when establishing a dosage regimen. These factors include the patient's current health status, their medical history, their physiological profile, and their specific biological response to the coenzyme.

Treatment often begins with a lower conservative dose. This initial phase allows the clinician to observe the patient's tolerance to the intramuscular delivery and the systemic introduction of the coenzyme. Based on these observations, the clinician may adjust the dosage or the frequency of the injections.

Patients must never attempt to adjust their dosage independently. Increasing the volume or the frequency of administration without clinical oversight can lead to adverse effects and disrupt the established treatment protocol. All modifications to the dosage must be formally directed by the prescribing professional.

Intramuscular Administration Procedures

NAD+ injections are administered intramuscularly. This means the fluid is delivered deep into a muscle mass, such as the vastus lateralis in the thigh or the ventrogluteal muscle in the hip. Intramuscular administration is chosen because muscle tissue is highly vascularized, allowing the coenzyme to be absorbed steadily into the bloodstream.

Proper technique is essential for safety and efficacy. The injection site must be thoroughly cleaned with an alcohol wipe. The needle is then inserted at a ninety-degree angle to ensure it reaches the deep muscle tissue rather than resting in the superficial subcutaneous fat layer.

Patients who self-administer the medication receive specific instructions on how to handle the syringe, how to measure the correct volume based on their dosage, and how to rotate injection sites. Rotating sites prevents tissue irritation and ensures consistent absorption over the duration of the treatment plan. Your clinician provides complete guidance on these physical procedures.

Clinical Evaluation and Purchasing

To begin a treatment protocol, patients complete an online intake process. Available where our clinicians and partner pharmacies are licensed; eligibility is confirmed during intake.

Upon clinical approval, patients can purchase the prescribed medication. Pricing is fixed and transparent. As of 2026, the NAD+ formulation is priced at $149.00 for a one-time purchase. It is also available on a monthly cadence for $149.00 per month.

You can complete the intake process, review your eligibility, and select your purchasing preference at https://joinbodygood.com/intake/nad-plus.